Personalized cancer care: new trial aims to improve outcomes in biliary cancer
NCT ID NCT05615818
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial is testing whether giving a targeted therapy after initial standard chemotherapy can help people with advanced biliary cancer live longer without their disease getting worse. Participants must have a tumor with a specific genetic change and stable disease after four cycles of chemo. They will be randomly assigned to receive either a matched targeted drug or continue standard care. The study aims to enroll 800 people across multiple countries.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Futibatinib, Ivosidenib, Zanidatamab, Trastuzumab, Neratinib, Encorafenib, Binimetinib
- What this could lead to
- If successful, this could offer a more effective, personalized maintenance treatment option for people with advanced biliary cancer whose tumors have specific genetic changes.
- What could go wrong
- This is a large phase 3 trial, but it only includes patients whose tumors have certain genetic markers, which may limit who can benefit. The targeted therapies also have their own side effects and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BILIARY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHM - CHU La Timone
NOT_YET_RECRUITINGMarseille, France
-
APHP - Hopital Henri Mondor
RECRUITINGCréteil, France
-
APHP - Hôpital Beaujon
RECRUITINGParis, France
-
APHP - Hôpital Cochin
RECRUITINGParis, France
-
APHP - Hôpital Paul Brousse
NOT_YET_RECRUITINGVillejuif, France
-
APHP - Hôpital Saint Antoine
RECRUITINGParis, France
-
Addenbrooke's Hospital
NOT_YET_RECRUITINGCambridge, United Kingdom
-
Bristol Haematology and Oncology Centre
RECRUITINGBristol, United Kingdom
-
CH Cornouaille
RECRUITINGQuimper, France
-
CH Valence
RECRUITINGValence, France
-
CH de Pau
RECRUITINGPau, France
-
CHRU de Nancy
RECRUITINGVandœuvre-lès-Nancy, France
-
CHU Amiens Picardie
RECRUITINGAmiens, France
-
CHU Charles Nicolle
NOT_YET_RECRUITINGRouen, France
-
CHU Dupuytren
RECRUITINGLimoges, France
-
CHU Estaing de Clermont Ferrand
RECRUITINGClermont-Ferrand, France
-
CHU Grenoble Alpes
NOT_YET_RECRUITINGGrenoble, France
-
CHU Lille
RECRUITINGLille, France
-
CHU Nantes - Hôtel Dieu
NOT_YET_RECRUITINGNantes, France
-
CHU Poitiers
RECRUITINGPoitiers, France
-
CHU Toulouse
RECRUITINGToulouse, France
-
CHU d'Angers
RECRUITINGAngers, France
-
CHU de Besançon
RECRUITINGBesançon, France
-
CHU de Bordeaux - Hôpital Haut-Leveque
NOT_YET_RECRUITINGBordeaux, France
-
CHU de Dijon
RECRUITINGDijon, France
-
CHU de Reims
RECRUITINGReims, France
-
Castle Hill Hospital
NOT_YET_RECRUITINGCottingham, United Kingdom
-
Centre Antoine Lacassagne
RECRUITINGNice, France
-
Centre Eugène Marquis
RECRUITINGRennes, France
-
Centre François Baclesse
RECRUITINGCaen, France
-
Centre Jean Perrin
RECRUITINGClermont-Ferrand, France
-
Centre Leon Bérard
NOT_YET_RECRUITINGLyon, France
-
Centre Oscar Lambret
RECRUITINGLille, France
-
Churchill Hospital
NOT_YET_RECRUITINGOxford, United Kingdom
-
Clatterbridge Cancer Centre NHS Foundation Trust
NOT_YET_RECRUITINGLiverpool, United Kingdom
-
Clinique Privée Jean Mermoz
NOT_YET_RECRUITINGLyon, France
-
Cliniques universitaires Saint-Luc
NOT_YET_RECRUITINGBrussels, Belgium
-
Cliniques universitaires de Bruxelles - Hôpital Erasme ULB
NOT_YET_RECRUITINGBrussels, Belgium
-
Groupe Hospitalier Diaconesses Croix Saint-Simon
NOT_YET_RECRUITINGParis, France
-
Groupe hospitalier mutaliste de Grenoble - Institut Daniel Hollard
RECRUITINGGrenoble, France
-
Gustave Roussy
RECRUITINGVillejuif, France
-
Guy's & St Thomas' Hospital
NOT_YET_RECRUITINGLondon, United Kingdom
-
Hammersmith Hospital
RECRUITINGLondon, United Kingdom
-
Hospices Civils de Lyon - Croix Rousse
RECRUITINGLyon, France
-
Hôpital Européen
RECRUITINGMarseille, France
-
Hôpital Foch
RECRUITINGSuresnes, France
-
Institut Curie - Saint Cloud
NOT_YET_RECRUITINGSaint-Cloud, France
-
Institut Jean Godinot
RECRUITINGReims, France
-
Institut Paoli Calmettes
RECRUITINGMarseille, France
-
Institut de Cancer de Montpellier
RECRUITINGMontpellier, France
-
Institut de Cancerologie de l'Ouest
NOT_YET_RECRUITINGSaint-Herblain, France
-
Institut de cancerologie de l'Ouest - Angers
RECRUITINGAngers, France
-
Institut du Cancer Avignon Provence
RECRUITINGAvignon, France
-
Institute Mutualiste Montsouris
RECRUITINGParis, France
-
Maidstone Hospital
NOT_YET_RECRUITINGMaidstone, United Kingdom
-
Mount Vernon Cancer Centre
RECRUITINGNorthwood, United Kingdom
-
North West Anglia NHS Foundation Trust
NOT_YET_RECRUITINGPeterborough, United Kingdom
-
Nottingham University Hospital
RECRUITINGNottingham, United Kingdom
-
Queen Elizabeth Hospital
RECRUITINGBirmingham, United Kingdom
-
Royal Free Hospital
NOT_YET_RECRUITINGLondon, United Kingdom
-
Royal Marsden Hospital
RECRUITINGLondon, United Kingdom
-
Singleton Hospital
NOT_YET_RECRUITINGSwansea, United Kingdom
-
Southampton General Hospital
NOT_YET_RECRUITINGSouthampton, United Kingdom
-
St James's Hospital
NOT_YET_RECRUITINGLeeds, United Kingdom
-
The Christie Hospital
NOT_YET_RECRUITINGManchester, United Kingdom
-
Universitair Ziekenhuis Antwerpen (UZA)
NOT_YET_RECRUITINGEdegem, Belgium
-
Universitair Ziekenhuis Leuven
NOT_YET_RECRUITINGLeuven, Belgium
-
University College London
RECRUITINGLondon, United Kingdom
-
Weston Park Cancer Centre
NOT_YET_RECRUITINGSheffield, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sound waves supercharge immunotherapy against bile duct cancer?
- Can a smaller incision offer the same cancer surgery outcome?
- Can blood tests reveal how liver and bile duct cancers respond to treatment?
- Can a One-Two punch of heat and drainage tame inoperable bile duct cancer?
- Can a pill target Hard-to-Treat bile duct cancers? a new drug puts FGFR2 mutations to the test
- Can matching drugs to tumor genes beat biliary cancer?